Process for the production of 3,4-epoxybutyrate and intermediate therefor

Abstract: A 3,4-epoxybutyrate of the formula: CCH-CH₂-COOR¹ wherein R¹ is an alkyl or aralkyl group is efficiently pre­ pared by a process comprising steps of: (a) reacting 3,4-dihydroxybutyronitrile of the formula: HO-CH₂CH₂-CN (II) with a sulfonyl chloride of the formula: R²-SO₂-Cl wherein R² is an alkyl group or a phenyl group which may be substituted in the presence of a base to obtain a compound of the formula: R²-SO₂-O-CH₂CH₂-CN (b) reacting the compound prepared in the step (a) with an alcohol of the formula: R¹-OH in the presence of an acid to obtain a compound of the formula: R²-SO₂-O-CH₂CH₂-COOR¹ and (c) reacting the compound prepared in the step (b) with a base to obtain the 3,4-epoxybutyrate.

Description: BACKGROUND OF THE INVENTION Field of the Invention The present invention relates to a process for the production of a 3,4-epoxybutyrate and an intermediate therefor. More particularly, the present invention relates to a process for the production of a 3,4-epoxybutyrate from 3,4-dihydroxybutyronitile and a 3,4-dihydroxybutyric acid derivative which is useful as an intermediate in the production of the 3,4-epoxybutyrate. Description of the Related Art A 3,4-epoxybutyrate of the formula: wherein R¹ is an alkyl or aralkyl group is easily converted to carnitine (see U.S. Patent Nos. 3,830,931 and 3,968,241), which is known as an aperitive or an agent for treating congestive heart failure or arrhythmia (see J. Org. Chem., 53 , 104 (1988)). The 3,4-epoxybutyrate (I) is also known as an important intermediate which can be easily converted to 4-hydroxy-2-oxo-1-pyrrolidineacetamide derivatives including 4-hydroxy-2-oxo-1-pyrrolidineacetamide (oxiracetam) known as an agent for improving cerabral metabolism (see Japanese Patent Kokai Publication Nos. 208957/1985, 461/1987 and 185069/1987). In addition, the 3,4-epoxybutyrate (I) can be used in the synthesis of γ-amino-β-hydroxybutyric acid (GABOB) which has an antiepileptic activity or an antihypertensive activity. As above, the 3,4-epoxybutyrate (I) is known to be converted to various biologically active substances or medicines. To prepare the 3,4-epoxybutyrate, the following major processes are known: (1) A process comprising epoxidizing a vinyl acetate with a peracid (see J. Pharm. Sci., 64 , 1262 (1975) and Japanese Patent Kokai Publication No. 10077/1987). (2) A process comprising methoxycarbonylating epichlorohydrin with carbon monooxide and methanol to obtain a 4-chloro-3-hydroxybutyrate and cyclizing said ester with silver oxide to obtain a 3,4-epoxybutyrate (see J. Org. Chem., 32 , 3888 (1967). However, the first process has problems such as handling of the organic peracid which is inherently corrosive and dangerous in mass scale and the use of heavy metal catalysts such as tungsten. Since the 3,4-epoxybutyrate (I) has one asymmetric carbon atom in a molecule, it contains two (R)- and (S)-enantiomers and further isomers of the ester (I) includes the (RS)-isomer (racemic mixture), (R)-isomer (optically active) and (S)-isomer (optically active). Recently, utility of optically active substances is increased in various fields such as pharmaceutical, agricultural and liquid crystal fields. By the above process (1), only the (RS)-isomer (racemic mixture) can be produced. Optical resolution of the racemic mixture with an enzyme is known (see Japanese Patent Kokai Publication Nos. 272983/1987 and 272984/1987). However, this optical resolution can provide only the (R)-isomer and the optical purity is unsatisfactory for some alkyl groups of the ester. By the process (1), no pure (S)-isomer is produced and pure (R)-isomers are produced for some esters. Therefore, it is desired to provide a process for producing both optical active isomers of the 3,4-epoxybutyrate (I). The above process (2) is not a commercially attractive process because it uses toxic carbon monooxide and produces the product only in a low yield, and silver oxide to be used for cyclization is expensive and should be recovered. EP-A-0 381 984, having a priority date of 23rd January 1989 and a filing date of 22nd January 1990, discloses a process for producing various 3- or 4-substituted oxotremorine derivatives. In one of these processes, the compound (S)-3-hydroxy-4-[[(4-methylphenyl)sulfonyl]oxy]butanoic acid methyl ester is used as an intermediate. EP-A-0 208 662, discloses a process for preparing tert-butyl-4-dimethylamino-3-hydroxy-butyrate which makes use of an enzymatic conversion of tert-butyl-4-chloro-acetoacetate to an optically active alcohol, and then converting this using Ag₂O to an epoxide. SUMMARY OF THE INVENTION One object of the present invention is to provide a process for the production of a 3,4-epoxybutyrate, which is economically attractive and easily carried out with good efficiency. Another object of the present invention is to provide a process for the production of optically active 3,4-epoxybutyrate. According to the present invention, there is provided a process for the production of a 3,4-epoxybutyrate of the formula: wherein R¹ is an alkyl or aralkyl group, which comprises steps of: (a) reacting 3,4-dihydroxybutyronitrile of the formula: with a sulfonyl chloride of the formula: R²-SO₂-Cl (III) wherein R² is an alkyl group or a phenyl group which may be optionally substituted by one, two or three methyl groups in the presence of a base to obtain a compound of the formula: wherein R² is the same as defined above, (b) reacting the compound (IV) obtained in the step (a) with an alcohol of the formula: R¹-OH (V) wherein R¹ is the same as defined above in the presence of an acid to obtain a compound of the formula: wherein R¹ and R² are the same as defined above, and (c) reacting the compound (VI) with a base to cyclize the compound (VI) to obtain the 3,4-epoxybutyrate. Since each of the compounds (I), (II), (IV) and (VI) has the asymmetric carbon atom at the 3-position, it has the (R)- and (S)-enantiomers. In the present invention, these compounds include the (R)-isomer, the (S)-isomer, the (RS)-isomer (namely, a racemic compound consisting of a 1:1 mixture of the (R)-isomer and the (S)-isomer) and a mixture which contains either one of the (R)-isomer and the (S)-isomer dominantly. DETAILED DESCRIPTION OF THE INVENTION Step (a) The 3,4-dihydroxybutyronitrile (II) as the starting material is a known compound and prepared by one of the processes described in the literatures as follows: The racemic compound 3,4-dihydroxybutyronitrile (II) is prepared by reacting a racemic compound 3-chloro-1,2-propanediol with KCN or NaCN (see J. Am. Chem. Soc., 107 , 7008 (1985). The (S)-isomer of the 3,4-dihydroxybutyronitrile (II) is selectively prepared by reacting (R)-3-chloro-1,2-propanediol, which is effectively prepared through stereo-selective biodegradation of racemic mixture 3-chloro-1,2-propanediol (see Japanese Patent Kokai Publication Nos. 122597/1987, 158494/1987 and 36798/1988), with NaCN or KCN under controlled conditions (see Japanese Patent Kokai Publication No. 42050/1990). The (R) isomer of the 3,4-dihydroxybutyronitrile (II) is prepared from L-ascorbic acid or D-sorbitol through several reactions (J. Am. Chem. Soc., 102 , 6304 (1980)). Then, the 3,4-dihydroxybutyronitrile (II) is reacted with the sulfonyl chloride (III) in the presence of a base. Herein, R² is an alkyl group or a phenyl group which may be substituted. Examples of R² are methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec.-butyl, pentyl, hexyl, heptyl, octyl, phenyl, p-tolyl, o-tolyl, m-tolyl, xylyl, mesityl and the like. Among them, methyl, phenyl and p-tolyl are preferred. In particular, p-tolyl is preferred. As the base, any of the conventionally used inorganic and organic bases can be used. Examples of the inorganic base are sodium hydroxide, potassium hydroxide, sodium carbonate, sodium hydrogencarbonate and the like. Examples of the organic base are trimethylamine, triethylamine, tributylamine, pyridine, picoline, lutidine and the like. Among them, pyridine and triethylamine are preferred, in particular, pyridine is preferred. A co-catalyst such as dimethylaminopyridine may be used. The reaction may be carried out in the absence of an additional solvent. That is, the organic base may be used as a reaction medium. If desired, an organic solvent which does not react with the reagents, in particular the sulfonyl chloride (III) may be used. Examples of such solvent are dichloromethane, ethyl acetate, dioxane, acetonitrile, dimethylformamide, dimethylsulfoxide, chloroform, carbon tetrachloride and the like. Preferably, the reaction is carried out in the absence of a solvent or in the presence of dichloromethane or ethyl acetate. In the above reaction, 0.5 to 5 moles, preferably 1.0 to 1.5 moles of the sulfonyl chloride (III) and 0.5 to 30 moles, preferably 1.0 to 15 moles of the base are used per one mole of the 3,4-dihydroxybutyronitrile (II). With the sulfonyl chloride (III), preferably an equimolar amount or an excess amount of the base is used. The reaction temperature is from -30°C to +100°C. When the solvent is used, a temperature from its melting point to its boiling point can be used. Preferably, the reaction temperature is from -30°C to +50°C. The reaction can be completed from one hour to one day. When the starting material is not consumed completely, additional amounts of the base and the sulfonyl chloride (III) are added. The reaction can be terminated by pouring the reaction mixture in cooled water or cooled dilute hydrochloric acid, or adding the cooled water or the cooled dilute hydrochloric acid to the reaction mixture. If desired, the solvent or the base may be beforehand evaporated off under reduced pressure. When water is added, it should be sufficiently cooled to prevent side reactions. After termination of the reaction, the base is optionally removed by washing the reaction mixture with water or acidic water, and the solvent is evaporated off under reduced pressure to recover a crude product. If desired, the crude product is purified by a conventional method such as by using a silica gel column chromatography to obtain the pure 3,4-dihydroxybutyronitrile derivative (IV). In this step (a), it is possible to selectively proceed the reaction on the primary hydroxy group on the 4-position among two hydroxy groups of the 3,4-dihydroxybutyronitrile (II) through control of the reaction temperature and the amounts of the base and the reagents so as to produce the compound (IV) in a good yield. Step (b) In the step (b), the 3,4-dihydroxybutyronitrile derivative (IV) obtained in the step (a) is used in the pure form or in the crude form. The reaction in the step (b) converts the nitrile group in the compound (IV) to the ester group: COOR¹. Therefore, any reaction that can covert the nitrile group to the ester group may be used. For example, the nitrile group is once converted to a carboxylic acid group and then converted to the ester group, or the nitrile group is once converted to an imidate group (iminoester) and then converted to the ester group. Since the compound (IV) has an easily eliminable group (R²SO₂-O-) in the molecule, the conditions are so selected that such group is not eliminated. Then, it is preferred that the acid is added to react with the alcohol: R¹-OH (V) to form the imidate which is converted to the ester with the addition of water. Herein, R¹ is an alkyl group or an aralkyl group, examples of which are methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec.-butyl, tert.-butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, benzyl, benzyl substituted with, for example, p-nitrobenzyl, and the like. Among them, methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec.-butyl, tert.-butyl, hexyl and octyl are preferred. Isobutyl is particularly preferred. As the acid, any of the organic and inorganic acids may be used. Examples are hydrogen chloride, hydrogen bromide, sulfuric acid, p-toluenesulfonic acid, and the like. Among them, hydrogen chloride is preferred. The reaction is initiated by the addition of the acid to the 3,4-dihydroxybutyronitrile derivative (IV) and the alcohol (V). When the acid is in the gas form, it is bubbled in the 3,4-dihydroxybutyronitrile derivative (IV) and the alcohol (V). When the consumption of the starting materials is confirmed, water is added to the reaction mixture to convert the product to the 3,4-dihydroxybutyrate derivative (VI). If desired, the reaction may be carried out in a solvent which is inert to the reaction. The alcohol (V) is used in an amount of 0.5 to 30 times equivalent, preferably 1 to 20 times equivalent to the compound (IV), and the acid is used in an amount of 0.5 to 30 times equivalent, preferably 1 to 10 times equivalent to the compound (IV). The reaction temperature is from -30°C to 100°C, preferably from 0°C to 50°C. Under the above conditions, the reaction is completed in about one hour to about 24 hours. Thereafter, water is added to the reaction mixture in an amount necessary to convert the imidate to the ester and the mixture is heated at 40°C for one hour to finalize the reaction. The reaction mixture is separated into two phases. After removing an aqueous phase, an organic layer is neutralized with a base such as sodium hydroxide and again separated. The organic phase is then concentrated under reduced pressure to obtain crude 3,4-dihydroxybutyrate derivative (VI). If necessary, the salt is filtered off, or the product is dried. Further, the product is purified by a conventional method, for example, by using silica gel column chromatography to obtain the pure compound (VI). In the step (b), the reaction is not influenced by the hydroxy group at the 3-position and the R²SO₂-O- group at 4-position, and the nitrile is converted to the ester in a good yield. The 3,4-dihydroxybutyrate derivatives (VI) are partly novel compounds which are a subject of the present invention and important intermediates in the synthesis of the 3,4-epoxybutyrate (I) of the present invention. As stated above, the compound (VI) has an asymmetric center and includes the racemic compound ((RS)-isomer), the (R)-isomer, the (S)-isomer and the mixture of the (R)-and (S)-isomers in an arbitrary ratio. Step (c) In the step (c), the 3,4-dihydroxybutyrate derivative (VI) obtained in the step (b) is used in the pure form or in the crude form. In the step (c), the R²-SO₂-O- group is eliminated with the base and an epoxy ring is formed at the 3- and 4-positions to obtain the 3,4-epoxybutyrate (I). The reaction can be carried out in a suitable solvent (e.g. water, hexane, methanol, ethanol, propanol, isopropanol, butanol, isobutanol, sec.-butanol, tert.-butanol, hexanol, octanol, tetrahydrofuran, dichloromethane, chloroform, carbon tetrachloride, ethyl acetate, acetonitrile, dioxane, dimethylformamide, mixtures thereof) or in a two or three phase system. As the base, any of inorganic and organic bases may be used. Examples of the inorganic base are sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, sodium hydrogencarbonate, potassium hydrogencarbonate and the like. Examples of the organic base are triethylamine, trimethylamine, tributylamine, pyridine, lutidine, picoline, sodium methoxide, sodium ethoxide, potassium tert.-butoxide and the like. Since the 3,4-epoxybutyrate (I) is unstable compound under basic conditions, a combination of the solvent and the base will have a significant influence on a yield of the product. Preferably, the compound (VI) is added to a mixture of hexane and water to proceed the reaction in the three phase system, and an aqueous phase is basified with a buffer such as sodium carbonate/sodium hydrogencarbonate, whereby the 3,4-epoxybutyrate (I) is produced in a good yield. Since by-products and the compound (VI) are hardly soluble in the hexane phase, the product (I) is mainly recovered through separation of the hexane phase after the reaction. The reaction temperature is from -30°C to +100°C. When the solvent is used, a temperature from its melting point to its boiling point can be used. Preferably, the reaction temperature is from 0°C to +80°C. The reaction time is from 10 minutes to 24 hours, preferably from 10 minutes to 5 hours. The base is used in an amount sufficient for capturing R²SO₂-OH which is by-produced in the reaction. After the reaction, water and a solvent necessary for separation are added to the reaction mixture, and the mixture is washed with water. In this post-treatment, pH of the aqueous phase is neutral or acidic. In such pH range, the stability of the 3,4-epoxybutyrate (I) is increased. After washing with water, the solvent is evaporated off under reduced pressure to obtain the crude 3,4-epoxybutyrate (I). The crude product can be purified by a conventional method, for example, by using silica gel column chromatography or distillation under reduced pressure to isolate the pure 3,4-epoxybutyrate (I). In the step (c), the 3,4-epoxybutyrate (I) is selectively produced while suppressing the side reactions. According to the present invention, the steps (a), (b) and (c) are successively performed to effectively produce the 3,4-epoxybutyrate (I) from the 3,4-dihydroxybutyronitrile (II). According to the present invention, either optically active substance of the (R)- and (S)-isomers can be freely produced. PREFERRED EMBODIMENTS OF THE INVENTION The present invention will be illustrated by following Examples. Example 1 Preparation of (3S)-3-hydroxy-4-p-toluenesulfonyloxybutyronitrile (3S)-3,4-Dihydroxybutyronitrile (43.1 g, 426 mmol), pyridine (240 ml) and tosyl chloride (119.5 g) were mixed at 0°C for 4 hours. The mixture was poured in ice-cooled 1N hydrochloric acid and stirred, followed by extraction with ethyl acetate. After the organic layer was dried over anhydrous sodium sulfate, the solvent was evaporated off with an evaporator. The residue was purified with silica gel column chromatography (hexane:ethyl acetate = 2:1) to obtain (3S)-3-hydroxy-4-p-toluenesulfonyloxybutyronitrile (87.0 g, 340 mmol). Yield, 80 %. ¹H-NMR (90 MHz, CDCl₃): δ (ppm) = 7.82 and 7.40 (d,d, 4H, J=7 Hz), 4.00-4.40 (m, 3H), 3.13 (s, 1H), 2.59 (d, 2H, J=5 Hz) and 2.48 (s, 3H). IR (neat): 3500, 2950, 2280, 1600, 1360, 1195 and 1100 cm⁻¹. [α] 25 / D = -16.62° (c = 1.72, ethanol). Example 2 Preparation of (3S)-3-hydroxy-4-p-toluenesulfonyloxybutyronitrile (3S)-3,4-Dihydroxybutyronitrile (161.8 g, 1.6 mol) was dissolved in pyridine (260 ml). To the resulting solution, a solution of tosyl chloride (396.6 g) in methylene chloride (1.6 liters) was added at 0°C and stirred at 0°C for 5 hours. Then, pH of the mixture was adjusted at 2 with 6N hydrochloric acid, and the mixture was extracted with methylene chloride. After the organic layer was dried over anhydrous sodium sulfate, the solvent was evaporated off. The residue was purified with silica gel column chromatography (hexane:ethyl acetate = 2:1) to obtain (3S)-3-hydroxy-4-p-toluenesulfonyloxybutyronitrile (85.9 g). Yield, 70 %. The physicochemical data were the same as those in Example 1. Example 3 Preparation of (3R)-3-hydroxy-4-p-toluenesulfonyl oxybutyronitrile In the same manner as in Example 1 but using (3R)-3,4-dihydroxybutyronitrile in place of (3S)-3,4-dihydroxybutyronitrile, the reaction and purification were carried out to obtain (3R)-3-hydroxy-4-p-toluenesulfonyloxybutyronitrile. Yield, 85 %. The results of ¹H-NMR and IR analysis were the same as those in Example 1. [α] 25 / D = +16.6° (c = 1.72, ethanol). Example 4 Preparation of (3RS)-3-hydroxy-4-p-toluenesulfonyloxybutyronitrile In the same manner as in Example 1 but using (3RS)-3,4-dihydroxybutyronitrile in place of (3S)-3,4-dihydroxybutyronitrile, the reaction and purification were carried out to obtain (3RS)-3-hydroxy-4-p-toluenesulfonyloxybutyronitrile. Yield, 78 %. The results of ¹H-NMR and IR analysis were the same as those in Example 1. Example 5 Preparation of (3S)-3-hydroxy-4-methanesulfonyloxybutyronitrile (3S)-3,4-Dihydroxybutyronitrile (8.0 g, 79.1 mmol), pyridine (19.1 ml) and mesyl chloride (7.33 ml) were mixed at 0°C for 6 hours. The mixture was poured in ice-cooled 1N hydrochloric acid and stirred, followed by extraction with ethyl acetate. After the organic layer was dried over anhydrous sodium sulfate, the solvent was evaporated off with an evaporator. The residue was purified with silica gel column chromatography (acetone:chloroform = 5:95) to obtain (3S)-3-hydroxy-4-methanesulfonyloxybutyronitrile (8.1 g) . Yield, 57 %. ¹H-NMR (CDCl₃/acetone-d₆): δ (ppm) = 4.80 (s, 1H), 4.35 (m, 3H), 3.18 (s, 3H) and 2.78 (d, 2H, J=6 Hz). IR (neat): 3500, 3050, 2950, 2270, 1420, 1340, 1170, 1110, 1000, 970 and 820 cm⁻¹. [α] 25 / D = -6.67° (c = 8.00, ethanol). Example 6 Preparation of (3S)-3-hydroxy-4-methanesulfonyloxybutyronitrile (3S)-3,4-Dihydroxybutyronitrile (16.2 g, 160 mmol) was dissolved in pyridine (26.0 ml). To the resulting solution, a solution of mesyl chloride (14.8 ml) in methylene chloride (160 ml) was added at 0°C and stirred at 0°C for 6 hours. Then, pH of the mixture was adjusted at 2 with 6N hydrochloric acid, and the mixture was extracted with methylene chloride. After the organic layer was dried over anhydrous sodium sulfate, the solvent was evaporated off. The residue was purified with silica gel column chromatography (acetone:chloroform = 5:95) to obtain (3S)-3-hydroxy-4-methanesulfonyloxybutyronitrile (15.2 g). Yield, 53 %. The physicochemical data were the same as those in Example 5. Example 7 Preparation of (3R)-3-hydroxy-4-methanesulfonyloxybutyronitrile In the same manner as in Example 5 but using (3R)-3,4-dihydroxybutyronitrile in place of (3S)-3,4-dihydroxybutyronitrile, the reaction and purification were carried out to obtain (3R)-3-hydroxy-4-methanesulfonyloxybutyronitrile. Yield, 62 %. The results of ¹H-NMR and IR analysis were the same as those in Example 5. [α] 25 / D = = +6.67° (c = 8.00, ethanol). Example 8 Preparation of (3RS)-3-hydroxy-4-methanesulfonyloxybutyronitrile In the same manner as in Example 5 but using (3RS)-3,4-dihydroxybutyronitrile in place of (3S)-3,4-dihydroxybutyronitrile, the reaction and purification were carried out to obtain (3RS)-3-hydroxy-4-methanesulfonyloxybutyronitrile. Yield, 65 %. The results of ¹H-NMR and IR analysis were the same as those in Example 5. Example 9 Preparation of isobutyl (3S)-3-hydroxy-4-(p-toluenesulfonyloxy)butyrate To (3S)-3-hydroxy-4-p-toluenesulfonyloxybutyronitrile (5.0 g, 19.6 mmol), isobutanol (25 ml) was added. Through the mixture, hydrogen chloride gas was bubbled to reach saturation and the mixture was stirred at room temperature for 18 hours. After confirming the consumption of the raw materials with high performance chromatography (reversed phase column: Finepak SILC₁₈₋₅, eluent: acetonitrile/water = 1/1), water (25 ml) was added and the mixture was heated at 40°C for one hour. Thereafter, an aqueous phase was removed from the separated mixture. The organic phase was neutralized with 5N sodium hydroxide, washed with water and concentrated under reduced pressure to obtain a crude product, which was determined with high performance chromatography (reversed phase column: Finepak SILC₁₈₋₅, eluent: acetonitrile/water = 1/1) to confirm that isobutyl (3S)-3-hydroxy-4-(p-toluenesulfonyloxy)butyrate was produced in the yield of 95 %. The crude product was purified with silica gel column chromatography (Wakogel C 200, eluent: hexane:ethyl acetate = 3:1) to obtain pure isobutyl (3S)-3-hydroxy-4-(p-toluenesulfonyloxy)butyrate as a colorless liquid (6.15 g, 18.6 mmol). ¹H-NMR (CDCl₃): δ(ppm) = 7.3 and 7.80 (dd, 4H, J=8 Hz), 3.94-4.38 (m, 3H), 3.85 (d, 2H, J=7 Hz), 2.96 (s, 2H), 2.51 (d, 2H, J=6 Hz), 2.42 (s, 3H), 1.69-2.15 (m, 1H) and 0.90 (d, 6H, J=6 Hz). IR (solution in CH₂Cl₂): 3600, 2980, 1730, 1380 and 1190 cm⁻¹. [α] 20 / D = -1.19° (c = 2.00, methanol). Example 10 Preparation of isobutyl (3S)-3,4-epoxybutyrate To isobutyl (3S)-3-hydroxy-4-(p-toluenesulfonyl-oxy)butyrate (1 g, 3.03 mmol), 1M sodium carbonate buffer (pH 10.8) (10 ml) and hexane (20 ml) were added and heated at 50°C for 4 hours. Then, the hexane phase was separated and washed with 0.1N hydrochloric acid and with water, followed by concentration under reduced pressure to obtain a crude product. The crude product was determined with gas chromatography (PEG column, 3 mm x 2 m, column temperature: 150°C) to find that isobutyl (3S)-3,4-epoxybutyrate was produced in a yield of 60 %. The crude product was vacuum evaporated (2 mmHg, b.p.: 40-42°C, bath temperature: 70°C) to obtain pure isobutyl (3S)-3,4-epoxybutyrate as a colorless liquid. [α] 20 / D = -22.46° (c = 2.00, methanol). ¹H-NMR (CDCl₃): δ(ppm) = 3.93 (d, 2H, J=6Hz), 3.45-3.15 (m, 1H), 2.94-2.76 (m, 3H), 2,70-2.48 (m, 3H), 2.22-1.71 (m, 1H) and 0.96 (d, 6H, J=8 Hz). IR (neat): 2950 and 1720 cm⁻¹. Example 11 Preparation of isobutyl (3S)-3-hydroxy-4-methane-sulfonyloxybutyrate To (3S)-3-hydroxy-4-methanesulfonyloxybutyronitrile (5.0 g, 27.9 mmol), isobutanol (25 ml) was added. Through the mixture, hydrogen chloride gas was bubbled to reach saturation and the mixture was stirred at room temperature for 18 hours. After confirming the consumption of the raw materials with preparative thin layer chromatography (silica gel: Gel 60 F-254, developer: chloroform/acetone = 1/1), water (25 ml),was added and the mixture was heated at 40°C for one hour. Thereafter, an aqueous phase was removed from the separated mixture. The organic phase was neutralized with 5N sodium hydroxide, washed with water and concentrated under reduced pressure to obtain a crude product. The crude product was purified with silica gel column chromatography (Wakogel C 300, eluent: chloroform) to obtain pure isobutyl (3S)-3-hydroxy-4-methanesulfonyloxybutyrate (5.68 g, 22.3 mmol). Isolation yield, 80 %. [α] 20 / D = -4.01° (c = 2.00, methanol). ¹H-NMR (CDCl₃): δ(ppm) = 4.15-4.42 (m, 3H), 3.92 (d, 2H, J=6 Hz), 3.46 (s, 1H), 3.09 (s, 3H), 2.62 (d, 2H, J=6Hz), 1.68-2.22 (m, 1H) and 0.93 (d, 6H, J=6 Hz). IR (solution in CCl₄): 3540, 2980, 1740, 1370 and 1190 cm⁻¹. Example 12 Preparation of isobutyl (3S)-3,4-epoxybutyrate To isobutyl (3S)-3-hydroxy-4-methanesulfonyloxybutyrate (1 g, 3.93 mmol), 1M sodium carbonate buffer (pH 10.8) (10 ml) and hexane (10 ml) were added and heated at 50°C for 1.5 hours. Then, the hexane phase was separated and washed with 0.1N hydrochloric acid and with water, followed by concentration under reduced pressure to obtain a crude product. The crude product was determined with gas chromatography (PEG column, 3 mm x 2 m, column temperature: 150°C) to find that isobutyl (3S)-3,4-epoxybutyrate was produced in a yield of 33 %. The crude product was vacuum evaporated (2 mmHg, b.p.: 40-42°C, bath temperature: 70°C) to obtain pure isobutyl (3S)-3,4-epoxybutyrate as a colorless liquid. Specific rotation, and the results of ¹H-NMR and IR analysis were the same as those in Example 10. Example 13 Preparation of isobutyl (3R)-3-hydroxy-4-(p-toluenesulfonyloxy)butyrate In the same manner as in Example 9 but using (3R)-3-hydroxy-4-p-toluenesulfonyloxybutyronitrile in place of (3S)-3-hydroxy-4-p-toluenesulfonyloxybutyronitrile, the reaction and purification were carried out to obtain isobutyl (3R)-3-hydroxy-4-(p-toluenesulfonyloxy)butyrate in the yield of 92 %. [α] 20 / D = +1.19° (c = 2.00, methanol). The results of ¹H-NMR and IR analysis were the same as those in Example 9. Example 14 Preparation of isobutyl (3R)-3,4-epoxybutyrate In the same manner as in Example 10 but using isobutyl (3R)-3-hydroxy-4-(p-toluenesulfonyloxy)butyrate in place of isobutyl (3S)-3-hydroxy-4-(p-toluenesulfonyloxy)butyrate, the reaction and purification were carried out to obtain isobutyl (3R)-3,4-epoxybutyrate in the yield of 55 %. [α] 20 / D =+22.46° (c = 2.00, methanol). The results of ¹H-NMR and IR analysis were the same as those in Example 10. Example 15 Preparation of isobutyl (3R)-3-hydroxy-4-methanesulfonyloxybutyrate In the same manner as in Example 11 but using (3R)-3-hydroxy-4-methanesulfonyloxybutyronitrile in place of (3S)-3-hydroxy-4-methanesulfonyloxybutyronitrile, the reaction and purification were carried out to obtain isobutyl (3R)-3-hydroxy-4-methanesulfonyloxybutyrate in the yield of 75 %. [α] 20 / D = +4.01° (c = 2.00, methanol). The results of ¹H-NMR and IR analysis were the same as those in Example 11. Example 16 Preparation of isobutyl (3R)-3,4-epoxybutyrate In the same manner as in Example 12 but using isobutyl (3R)-3-hydroxy-4-methanesulfonyloxybutyrate in place of isobutyl (3S)-3-hydroxy-4-methanesulfonyloxybutyrate, the reaction and purification were carried out to obtain isobutyl (3R)-3,4-epoxybutyrate in the yield of 30 %. Specific rotation, the results of ¹H-NMR and IR analysis were the same as those in Example 14. Example 17 Preparation of isobutyl (3RS)-3-hydroxy-4-(p-toluenesulfonyloxy)butyrate In the same manner as in Example 9 but using (3RS)-3-hydroxy-4-(p-toluenesulfonyloxy)butyronitrile in place of (3S)-3-hydroxy-4-(p-toluenesulfonyloxy)butyronitrile, the reaction and purification were carried out to obtain isobutyl (3RS)-3-hydroxy-4-(p-toluenesulfonyloxy)butyrate in the yield of 94 %. The results of ¹H-NMR and IR analysis were the same as those in Example 9. Example 18 Preparation of isobutyl (3RS)-3,4-epoxybutyrate In the same manner as in Example 10 but using isobutyl (3RS)-3-hydroxy-4-(p-toluenesulfonyloxy)butyrate in place of isobutyl (3S)-3-hydroxy-4-(p-toluenesulfonyloxy)butyrate, the reaction and purification were carried out to obtain isobutyl (3RS)-3,4-epoxybutyrate in the yield of 55 %. The results of ¹H-NMR and IR analysis were the same as those in Example 10. Example 19 Preparation of isobutyl (3RS)-3-hydroxy-4-methanesulfonyloxybutyrate In the same manner as in Example 11 but using (3RS)-3-hydroxy-4-methanesulfonyloxybutyronitrile in place of (3S)-3-hydroxy-4-methanesulfonyloxybutyronitrile, the reaction and purification were carried out to obtain isobutyl (3RS)-3-hydroxy-4-methanesulfonyloxybutyrate in the yield of 78 %. The results of ¹H-NMR and IR analysis were the same as those in Example 11. Example 20 Preparation of isobutyl (3RS)-3,4-epoxybutyrate In the same manner as in Example 12 but using isobutyl (3RS)-3-hydroxy-4-methanesulfonyloxybutyrate in place of isobutyl (3S)-3-hydroxy-4-methanesulfonyloxybutyrate, the reaction and purification were carried out to obtain isobutyl (3RS)-3,4-epoxybutyrate in the yield of 35 %. The results of ¹H-NMR and IR analysis were the same as those in Example 10.

Claims: Claims for the following Contracting States : DE, GB, FR, IT, NL, CH, BE, LI A process for the production of a 3,4-epoxybutyrate of the formula: wherein R¹ is an alkyl or aralkyl group, which comprises the steps of: (a) reacting 3,4-dihydroxybutyronitrile of the formula: with a sulfonyl chloride of the formula: R²-SO₂-Cl (III) wherein R² is an alkyl group or a phenyl group which may be optionally substituted by one, two or three methyl groups in the presence of a base to obtain a compound of the formula: wherein R² is the same as defined above, (b) reacting the compound (IV) obtained in the step (a) with an alcohol of the formula: R¹-OH (V) wherein R¹ is the same as defined above in the presence of an acid to obtain a compound of the formula: wherein R¹ and R² are the same as defined above, and (c) reacting the compound (VI) with a base to cyclize the compound (VI) to obtain the 3,4-epoxybutyrate. The process according to claim 1, wherein optically active (3S)-3,4-dihydroxybutyronitrile is used as the compound (II), and (3S)-3,4-epoxybutyrate is prepared. The process according to claim 1, wherein optically active (3R)-3,4-dihydroxybutyronitrile is used as the compound (II), and (3R)-3,4-epoxybutyrate is prepared. A 3,4-dihydroxybutyric acid derivative of the formula: wherein R¹ is an alkyl or aralkyl group and R² is an alkyl group or a phenyl group which may be optionally substituted by one, two or three methyl groups with the proviso that if R¹ is a methyl group and the configuration is (3S), then R² does not represent a para-tolyl group. The 3,4-dihydroxybutyric acid derivative according to claim 4, which is a compound of the formula: wherein R¹ and R² are the same as defined above having the (3S)-configuration with the proviso that if R¹ is a methyl group, then R² does not represent a para-tolyl group. The 3,4-dihydroxybutyric acid derivative according to claim 4, which is a compound of the formula: wherein R¹ and R² are the same as defined above having the (3R)-configuration. The use of a 3,4-dihydroxybutyric acid derivative of the formula: wherein R¹ is an alkyl or aralkyl group and R² is an alkyl group or phenyl group which may be optionally substituted by one, two or three methyl groups as an intermediate in the synthesis of a 3,4-epoxybutyrate of the formula: wherein R¹ is as defined above. Claims for the following Contracting State : ES A process for the production of a 3,4-epoxybutyrate of the formula: wherein R¹ is an alkyl or aralkyl group, which comprises the steps of: (a) reacting 3,4-dihydroxybutyronitrile of the formula: with a sulfonyl chloride of the formula: R²-SO₂-Cl (III) wherein R² is an alkyl group or a phenyl group which may be optionally substituted by one, two or three methyl groups in the presence of a base to obtain a compound of the formula: wherein R² is the same as defined above, (b) reacting the compound (IV) obtained in the step (a) with an alcohol of the formula: R¹-OH (V) wherein R¹ is the same as defined above in the presence of an acid to obtain a compound of the formula: wherein R¹ and R² are the same as defined above, and (c) reacting the compound (VI) with a base to cyclize the compound (VI) to obtain the 3,4-epoxybutyrate. The process according to claim 1, wherein optically active (3S)-3,4-dihydroxybutyronitrile is used as the compound (II), and (3S)-3,4-epoxybutyrate is prepared. The process according to claim 1, wherein optically active (3R)-3,4-dihydroxybutyronitrile is used as the compound (II), and (3R)-3,4-epoxybutyrate is prepared. The use of a 3,4-dihydroxybutyric acid derivative of the formula: wherein R¹ is an alkyl or aralkyl group and R² is an alkyl group or phenyl group which may be optionally substituted by one, two or three methyl groups as an intermediate in the synthesis of a 3,4-epoxybutyrate of the formula: wherein R¹ is as defined above. The use according to claim 4, wherein the compound of formula (VI) has the formula: wherein R¹ and R² are the same as defined in claim 4 having the (3S)-configuration. The use according to claim 4, wherein the compound of formula (VI) has the formula: wherein R¹ and R² are the same as defined in claim 4 having the (3R)-configuration.

Inventors: HAYASHI SHIGEO, INOUE KENJI, TAKAHASHI SATOMI, TAOKA NAOAKI, UEYAMA NOBORU, HAYASHI, SHIGEO, INOUE, KENJI, TAKAHASHI, SATOMI, TAOKA, NAOAKI, UEYAMA, NOBORU
Applicants: KANEGAFUCHI CHEMICAL IND, KANEGAFUCHI CHEMICAL INDUSTRY CO., LTD.
Application year: 1990
Main classification: C07D303
IPC codes: C07C309, C07D303, C07C303